14403-3400Level 3
Liraglutide (Liraglutide)
**Product type:** Human Prescription Drug
**Active ingredient:** LIRAGLUTIDE
**Strength:** 18 mg/3mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
**Marketing category:** ANDA (ANDA215503)
**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/14403-3400Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.